2009 IoN News Archive
- Grant for research into new epilepsy treatments
- Professor Martin Rossor has been recognised by the The Alzheimer's Association
- Drug discovery collaboration on inclusion body myositis
- PDS awards Training Fellowship to Institute of Neurology researcher to understand how the brain controls Parkinson’s symptoms
- Alan Thompson to lead UCL Partners Neurological Disorders theme
- World MS Day - Wednesday 27th May - Global initiative to highlight Multiple Sclerosis
- Queen Square leads on new UK recommendations for bladder management which can dramatically improve quality of life in Multiple Sclerosis
- John Hardy most-cited Alzheimer's disease researcher in the UK
- Prestigious awards for Institute researchers
- Drug study offers hope for Alzheimer’s treatment
- Brain activity predicts our choices
- Professor George du Boulay CBE, FRCR, FRCP
- Brain awareness week: the impact of UCL research
- Parkinson's-linked mutation makes neurons vulnerable to calcium-induced death
- Second round of NIHR Senior Investigators announced
- 'Mind-Reading' Experiment Highlights How Brain Records Memories
- Anti-malaria drug does not appear to help with human prion diseases.
- UCL Partners is one of UK’s first Academic Health Science Centres
- "Opening doors for patients with MS"
- Are we as decisive as we think?
- "Magnets stop the nightmare of tinnitus, researchers say."
- Prestigious award for Professor Hugh Bostock
- Untangling the Brain
- Young UCL Investigator Award in neuroimaging techniques
- Brain disease "resistance gene" could offer insights into CJD
- Neurology: A Queen Square Textbook
- Headache: annual evidence update
- Roads closed for powerful MRI scanner delivery
- Long-term risks lower for surgical treatment of carotid stenosis
- Memorandum of collaboration signed
- Professor John Hardy joins the ranks of science greats
- Drug study offers hope for Alzheimer's treatment
- Prestigious award for Professor David Miller
- Magnets stop the nightmare of tinnitus, researchers say.
- Brain activity predicts our choices
- Jon Driver Award
- Professor Sander named recipient of the American Epilepsy Society 2009 Clinical Science Award
- Study highlights effect of brain waves on human behaviour
- New podcast describes the significance and impact of highly cited paper
- NIH Grant for research into inherited neuropathies
- How the brain knows a dog is a dog: concept acquisition in the human brain
- Prof Elizabeth Fisher elected member of the European Molecular Biology Organization (EMBO)
- Locating literacy in the brain
- Dopamine enhances expectation of pleasure in humans
- Queen Square scientists question memory theory
- IoN scientist to front Alzheimer’s Research Trust national appeal
- New doors open to the understanding of the origin of brain tumours
Published: Jan 21, 2015 12:20:24 PM
Published: Feb 24, 2014 2:53:53 PM
Published: Feb 20, 2014 6:58:34 PM
Published: Oct 10, 2014 5:54:41 PM
Published: Mar 10, 2015 3:07:15 PM
Published: Jan 28, 2015 9:37:32 AM
Published: Mar 18, 2015 12:49:06 PM
John Hardy most-cited Alzheimer's disease researcher in the UK
8 May 2009
With more than 23,000 citations in the period between January 1985 to April 2008, Professor John Hardy (Reta Lila Weston Institute of Neurological Studies) has been confirmed as the most highly cited author on Alzheimer's disease research in the UK and 5th internationally, according to a recent study published in the Journal of Alzheimer's Disease. * Professor Hardy published a total of 351 articles on Alzheimer's disease, making him the ninth most prolific in that same period.
Professor Hardy's main line of investigation are tau proteins, which in patients with Alzheimer's accumulate in abnormal folds. Changes in tau proteins lead to the disintegration of microtubules in brain cells, which are significant to many cellular processes including mitosis and vesicular transport.
More widely, Professor Hardy's research interests include the genetic analysis of disease, in conditions such as Parkinson's disease and other movement disorders, and he is ranked 13th in the world in the field of Neuroscience & Behaviour, by Thompson Reuters Essential Science Indicators.
The citation study of the field of Alzheimer's disease was undertaken with the underlying goal of understanding its importance within the field of neurodegenerative diseases and subsequently within the greater realm of neuroscience research.
* Aaron A. Sorensen. Alzheimer's Disease Research: Scientific Productivity and impact of the top 100 investigators in the field. Journal of Alzheimer's Disease 16 (2009) 451-465 DOI 10.3233/JAD-2009-1046
Page last modified on 26 oct 09 13:23